Skip to main content

Ana Barreira Diaz

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Ana Barreira Diaz

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Projects

Impact of HLA haplotypes and HDV viremia in developing of clinical events and quality of life of patients with chronic hepatitis delta.

IP: Maria Buti Ferret
Collaborators: Maria Jose Herrero Mata, Ana Barreira Diaz, Maria del Mar Riveiro Barciela, Jordi Llaneras Artigues, Adriana Palom Agusti
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI20/01692
Duration: 01/01/2021 - 30/06/2025

Related news

This tool will help avoid invasive techniques and assist in selecting candidates for clinical trials of new treatments.

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Related professionals

Ruben Fernández Galera

Ruben Fernández Galera

Postdoctoral researcher
Cardiovascular Diseases
Read more
Alba Estela García Fernández

Alba Estela García Fernández

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Nataly Reyes Calderon

Nataly Reyes Calderon

Predoctoral researcher
General Surgery
Read more
Daniel Alvarez De la Sierra

Daniel Alvarez De la Sierra

Research technician
Translational Immunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.